American Journal of Epidemiology Advance Access originally published online on November 9, 2006
American Journal of Epidemiology 2006 164(12):1253; doi:10.1093/aje/kwk081
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.
LETTERS TO THE EDITOR |
RE: "ANTIBIOTIC USE AND RISK OF MULTIPLE SCLEROSIS"
1 Department of Neurology, University of Sydney, Sydney, New South Wales 2006, Australia
2 Department of Medical Microbiology, University of Dundee, Dundee, Scotland DD1 4HN, United Kingdom
3 Department of Neurology, Tayside University Teaching Hospitals, Dundee, Scotland DD1 9SY, United Kingdom
(e-mail: jparratt@med.usyd.edu.au)
| The first 10% of the full text of this article appears below. |
Alonso et al. (1) demonstrated that premorbid antibiotic treatment of patients with multiple sclerosis, active against the respiratory pathogen Chlamydophila (previously Chlamydia) pneumoniae, did
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Alonso, S. S. Jick, and M. A. Hernan THREE AUTHORS REPLY Am. J. Epidemiol., December 15, 2006; 164(12): 1253 - 1254. [Full Text] [PDF] |
||||
